Skip to main content
Erschienen in: Surgical Endoscopy 12/2016

08.04.2016

Long-term efficacy of modified retrievable stents for treatment of achalasia cardia

verfasst von: Jun Dai, Yufeng Shen, Xiaobo Li, Yunjie Gao, Yan Song, Zhizheng Ge

Erschienen in: Surgical Endoscopy | Ausgabe 12/2016

Einloggen, um Zugang zu erhalten

Abstract

Aim

To investigate the efficacy, safety and optimal duration of placement of modified retrievable metal stents for treatment of achalasia cardia.

Methods

Patients were randomly divided into groups A (N = 26, modified stents for 3 days), B (N = 26, modified stents for 2 days), C (N = 24, balloon dilation), and D (N = 25, regular stents for 2 days). Clinical symptom scores were recorded at baseline, 6 months, and during long-term follow-up.

Results

Seventy-seven patients with achalasia underwent stent placement (100 % success rate of implantation and extraction, no perforation). No stent migration or drop-off occurred in groups A and B. In group D, stent drop-off and migration was observed in 2 and 1 patients, respectively. Two patients in group C sustained esophageal perforation. Patients in the modified stent (A and B), balloon dilated (C) and regular stents (D) groups experienced significant improvement in dysphagia at 6 months, with recurrence in 1.92, 8.33 and 28 %, respectively. The clinical symptom score in the modified stent groups was significantly lower than that in the balloon dilated group (P = 0.01). During long-term follow-up, the symptom scores in modified stent groups were significantly lower than that in the balloon dilated (P < 0.01) and regular stent (P < 0.01) groups.

Conclusion

Modified retrievable metal stents required an optimal placement duration of 2 days were safe with no incidence of migration or drop-off and had a lower recurrence of symptoms.
Literatur
1.
Zurück zum Zitat Vaezi MF, Richter JE (1999) Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol 94:3406–3412CrossRefPubMed Vaezi MF, Richter JE (1999) Diagnosis and management of achalasia. American College of Gastroenterology Practice Parameter Committee. Am J Gastroenterol 94:3406–3412CrossRefPubMed
2.
Zurück zum Zitat Francis DL, Katzka DA (2010) Achalasia: update on the disease and its treatment. Gastroenterology 139:369–374CrossRefPubMed Francis DL, Katzka DA (2010) Achalasia: update on the disease and its treatment. Gastroenterology 139:369–374CrossRefPubMed
3.
Zurück zum Zitat Eckardt VF (2001) Clinical presentations and complications of achalasia. Gastrointest Endosc Clin N Am 11(2):281–292PubMed Eckardt VF (2001) Clinical presentations and complications of achalasia. Gastrointest Endosc Clin N Am 11(2):281–292PubMed
4.
Zurück zum Zitat Hulselmans M, Vanuytsel T, Degreef T, Sifrim D, Coosemans W, Lerut T, Tack J (2010) Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 8:30–35CrossRefPubMed Hulselmans M, Vanuytsel T, Degreef T, Sifrim D, Coosemans W, Lerut T, Tack J (2010) Long-term outcome of pneumatic dilation in the treatment of achalasia. Clin Gastroenterol Hepatol 8:30–35CrossRefPubMed
5.
Zurück zum Zitat Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, Rice TW (2006) The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 4:580–587CrossRefPubMed Vela MF, Richter JE, Khandwala F, Blackstone EH, Wachsberger D, Baker ME, Rice TW (2006) The long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasia. Clin Gastroenterol Hepatol 4:580–587CrossRefPubMed
6.
Zurück zum Zitat Campos GM, Vittinghoff E, Rabl C et al (2009) Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 249:45–57CrossRefPubMed Campos GM, Vittinghoff E, Rabl C et al (2009) Endoscopic and surgical treatments for achalasia: a systematic review and meta-analysis. Ann Surg 249:45–57CrossRefPubMed
7.
Zurück zum Zitat Wang L, Li YM, Li L (2009) Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 54:2303–2311CrossRefPubMed Wang L, Li YM, Li L (2009) Meta-analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 54:2303–2311CrossRefPubMed
8.
Zurück zum Zitat Wang L, Li YM, Li L et al (2008) A systematic review and meta-analysis of the Chinese literature for the treatment of achalasia. World J Gastroenterol 14:5900–5906CrossRefPubMedPubMedCentral Wang L, Li YM, Li L et al (2008) A systematic review and meta-analysis of the Chinese literature for the treatment of achalasia. World J Gastroenterol 14:5900–5906CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Jones EL, Meara MP, Pittman MR, Hazey JW, Perry KA (2016) Prior treatment does not influence the performance or early outcome of per-oral endoscopic myotomy for achalasia. Surg Endosc 30(4):1282–1286CrossRefPubMed Jones EL, Meara MP, Pittman MR, Hazey JW, Perry KA (2016) Prior treatment does not influence the performance or early outcome of per-oral endoscopic myotomy for achalasia. Surg Endosc 30(4):1282–1286CrossRefPubMed
10.
Zurück zum Zitat Friedel D, Modayil R, Iqbal S, Grendell JH, Stavropoulos SN (2013) Per-oral endoscopic myotomy for achalasia: an American perspective. World J Gastrointest Endosc 5:420–427CrossRefPubMedPubMedCentral Friedel D, Modayil R, Iqbal S, Grendell JH, Stavropoulos SN (2013) Per-oral endoscopic myotomy for achalasia: an American perspective. World J Gastrointest Endosc 5:420–427CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Verlaan T, Rohof WO, Bredenoord AJ, Eberl S, Rösch T, Fockens P (2013) Effect of peroral endoscopic myotomy on esophagogastric junction physiology in patients with achalasia. Gastrointest Endosc 78:39–44CrossRefPubMed Verlaan T, Rohof WO, Bredenoord AJ, Eberl S, Rösch T, Fockens P (2013) Effect of peroral endoscopic myotomy on esophagogastric junction physiology in patients with achalasia. Gastrointest Endosc 78:39–44CrossRefPubMed
12.
Zurück zum Zitat Von Renteln D, Fuchs KH, Fockens P, Bauerfeind P, Vassiliou MC, Werner YB, Fried G, Breithaupt W, Heinrich H, Bredenoord AJ, Kersten JF, Verlaan T, Trevisonno M, Rösch T (2013) Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology 145:309–311CrossRef Von Renteln D, Fuchs KH, Fockens P, Bauerfeind P, Vassiliou MC, Werner YB, Fried G, Breithaupt W, Heinrich H, Bredenoord AJ, Kersten JF, Verlaan T, Trevisonno M, Rösch T (2013) Peroral endoscopic myotomy for the treatment of achalasia: an international prospective multicenter study. Gastroenterology 145:309–311CrossRef
13.
Zurück zum Zitat Zhao JG, Li YD, Cheng YS et al (2009) Long term safety and outcome of a temporary self-expanding metallic stent for achalasia: prospective study with a 13 year single center experience. Eur Radiol 19:1973–1980CrossRefPubMedPubMedCentral Zhao JG, Li YD, Cheng YS et al (2009) Long term safety and outcome of a temporary self-expanding metallic stent for achalasia: prospective study with a 13 year single center experience. Eur Radiol 19:1973–1980CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Athanasios DS, Chrysoula M, George DD et al (2015) Self-expandable metal stents for achalasia: thinking out of box. World J Gastrointest Endosc 7:45–52CrossRef Athanasios DS, Chrysoula M, George DD et al (2015) Self-expandable metal stents for achalasia: thinking out of box. World J Gastrointest Endosc 7:45–52CrossRef
15.
Zurück zum Zitat Cai XB, Dai YM, Zhou H et al (2013) Comparison between botulinum injection and removable covered self-expanding metal stents for the treatment of achalasia. Dig Dis Sci 58:1960–1966CrossRefPubMed Cai XB, Dai YM, Zhou H et al (2013) Comparison between botulinum injection and removable covered self-expanding metal stents for the treatment of achalasia. Dig Dis Sci 58:1960–1966CrossRefPubMed
16.
Zurück zum Zitat Chen YS, Ma F, Wu CG et al (2010) Temporary self-expanding metallic stents for achalasia: a prospective study with a long-term follow-up. World J Gastrointest Endosc 16:5110–5117 Chen YS, Ma F, Wu CG et al (2010) Temporary self-expanding metallic stents for achalasia: a prospective study with a long-term follow-up. World J Gastrointest Endosc 16:5110–5117
17.
Zurück zum Zitat Dai J, Shen YF, Ge ZZ et al (2012) Efficacy of implantation of a modified temporary metallic stent for cardia achalasia. Chin J Dig Endosc 29:19–23 Dai J, Shen YF, Ge ZZ et al (2012) Efficacy of implantation of a modified temporary metallic stent for cardia achalasia. Chin J Dig Endosc 29:19–23
18.
Zurück zum Zitat Yaghoobi M, Mikaeli J, Montazeri G et al (2003) Correlation between clinical severity score and the lower esophageal sphincter relaxation pressure in idiopathic achalasia. Am J Gastroenterol 98:278–283CrossRefPubMed Yaghoobi M, Mikaeli J, Montazeri G et al (2003) Correlation between clinical severity score and the lower esophageal sphincter relaxation pressure in idiopathic achalasia. Am J Gastroenterol 98:278–283CrossRefPubMed
19.
Zurück zum Zitat Diaz RAB, Sampascual SB, Calderon AJ et al (2009) Self-expanding esophageal prostheses as an alternative temporary treatment for achalasia. Gastrointest Endosc 69(4):980CrossRef Diaz RAB, Sampascual SB, Calderon AJ et al (2009) Self-expanding esophageal prostheses as an alternative temporary treatment for achalasia. Gastrointest Endosc 69(4):980CrossRef
20.
Zurück zum Zitat Werner YB, Costamagna G, Swanstrom LL et al (2015) Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut 0:1–8 (Gut Online first, published on April 30, 2015) Werner YB, Costamagna G, Swanstrom LL et al (2015) Clinical response to peroral endoscopic myotomy in patients with idiopathic achalasia at a minimum follow-up of 2 years. Gut 0:1–8 (Gut Online first, published on April 30, 2015)
Metadaten
Titel
Long-term efficacy of modified retrievable stents for treatment of achalasia cardia
verfasst von
Jun Dai
Yufeng Shen
Xiaobo Li
Yunjie Gao
Yan Song
Zhizheng Ge
Publikationsdatum
08.04.2016
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 12/2016
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-016-4879-9

Weitere Artikel der Ausgabe 12/2016

Surgical Endoscopy 12/2016 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.